Fumio Sugawara Selected Research

pyrenocine A

12/2019

Pyrenocine A induces monopolar spindle formation and suppresses proliferation of cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fumio Sugawara Research Topics

Disease

46	Neoplasms (Cancer) 01/2022 - 01/2002
6	Infections 01/2019 - 11/2013
4	Carcinoma (Carcinomatosis) 03/2019 - 11/2009
4	Inflammation (Inflammations) 08/2010 - 05/2005
3	Neuroblastoma 05/2008 - 05/2004
3	Stomach Neoplasms (Stomach Cancer) 07/2002 - 02/2002
2	Hypoxia (Hypoxemia) 01/2022 - 01/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2016 - 07/2004
2	Parkinson Disease (Parkinson's Disease) 01/2011 - 05/2008
1	Malignant Mesothelioma 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Human Influenza (Influenza) 07/2019
1	Nervous System Diseases (Neurological Disorders) 04/2016
1	Wounds and Injuries (Trauma) 04/2016
1	Stroke (Strokes) 04/2016
1	Hepatitis B 12/2015
1	Reinfection 12/2015
1	Hepatocellular Carcinoma (Hepatoma) 01/2015
1	Edema (Dropsy) 08/2014
1	Anaphylaxis (Anaphylactic Shock) 08/2014
1	Hepatitis A (Hepatitis, Infectious) 12/2013
1	Autoimmune Diseases (Autoimmune Disease) 01/2013
1	Rheumatoid Arthritis 01/2013

Drug/Important Bio-Agent (IBA)

11	DNA (Deoxyribonucleic Acid)IBA 08/2013 - 05/2005
11	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 08/2013 - 01/2003
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2005
5	Pharmaceutical PreparationsIBA 12/2015 - 07/2005
5	Type I DNA Topoisomerases (Topoisomerase I)IBA 08/2013 - 01/2010
4	trioctyl phosphine oxide (TOPO)IBA 08/2013 - 05/2005
4	EnzymesIBA 08/2013 - 05/2005
4	Small Interfering RNA (siRNA)IBA 08/2012 - 02/2008
3	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 02/2002
3	Deoxyribonuclease I (Nickase)IBA 08/2013 - 05/2005
3	Type II DNA Topoisomerases (Topoisomerase II)IBA 05/2011 - 10/2003
3	GemininIBA 06/2008 - 02/2008
3	epolactaeneIBA 05/2008 - 05/2004
3	dehydroaltenusinIBA 01/2007 - 02/2002
2	Radiation-Sensitizing AgentsIBA 01/2022 - 01/2021
2	Biological ProductsIBA 07/2019 - 12/2011
2	MA026IBA 05/2017 - 12/2013
2	Tamoxifen FDA LinkGeneric 09/2015 - 01/2013
2	RoxithromycinIBA 01/2015 - 01/2013
2	Polynucleotide 5'-Hydroxyl-Kinase (Kinase, Polynucleotide)IBA 08/2013 - 11/2009
2	bacteriophage T7 RNA polymerase (T7 RNA polymerase)IBA 08/2013 - 11/2009
2	IMP DehydrogenaseIBA 08/2013 - 11/2009
2	Cisplatin (Platino)FDA LinkGeneric 11/2012 - 07/2005
2	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2012 - 11/2009
2	1- mono- O- acyl- 3- O- (alpha- D- sulfoquinovosyl)- glycerideIBA 08/2012 - 05/2008
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 12/2011 - 11/2005
2	CamptothecinIBA 12/2011 - 11/2005
2	Etoposide (VP 16)FDA LinkGeneric 05/2011 - 07/2005
2	1-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA 01/2011 - 05/2008
2	neoechinulin AIBA 01/2011 - 07/2004
2	NeurotoxinsIBA 01/2011 - 05/2008
2	DiglyceridesIBA 09/2009 - 10/2003
2	DNA Polymerase I (Klenow Fragment)IBA 01/2007 - 05/2005
2	GlycolipidsIBA 01/2007 - 07/2002
2	sulfoquinovosylacylglycerolIBA 01/2006 - 11/2005
2	Immunosuppressive Agents (Immunosuppressants)IBA 10/2003 - 02/2003
2	sulfolipidsIBA 10/2003 - 01/2002
2	Fatty Acids (Saturated Fatty Acids)IBA 07/2002 - 01/2002
1	Messenger RNA (mRNA)IBA 01/2022
1	AsbestosIBA 01/2022
1	Thromboplastin (Tissue Factor)IBA 01/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2021
1	pyrenocine AIBA 12/2019
1	NucleosidesIBA 07/2019
1	sulfoquinovosylacylpropanediolIBA 03/2019
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019
1	Chloramphenicol (Chloromycetin)FDA Link 01/2019
1	LipidsIBA 12/2018
1	Gadolinium DTPA (Magnevist)FDA Link 12/2018
1	Oxyhemoglobins (Oxyhemoglobin)IBA 12/2018
1	Oxygen (Dioxygen)IBA 12/2018
1	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 12/2018
1	Claudin-1IBA 05/2017
1	Glutamic Acid (Glutamate)FDA Link 04/2016
1	vanitaracin AIBA 12/2015
1	sodium-bile acid cotransporterIBA 12/2015
1	PolyketidesIBA 12/2015
1	Antiviral Agents (Antivirals)IBA 12/2015
1	ridaifen GIBA 09/2015
1	MacrolidesIBA 01/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2015
1	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2015
1	karuquinone BIBA 09/2014
1	karuquinone AIBA 09/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2014
1	Anti-Allergic Agents (Antiallergic Agents)IBA 08/2014
1	4-hydroxyphenylethanolIBA 08/2014
1	Immunoglobulin E (IgE)IBA 08/2014
1	sulochrinIBA 11/2013
1	catechol (pyrocatechol)IBA 08/2013
1	Methotrexate (Mexate)FDA LinkGeneric 01/2013

Therapy/Procedure

4	Radiotherapy 01/2022 - 12/2018
2	Intravenous Injections 03/2019 - 12/2018
2	Drug Therapy (Chemotherapy) 01/2013 - 10/2003
2	Transplantation 10/2003 - 02/2003
1	Radioimmunotherapy 01/2022
1	Intravenous Administration 03/2019